# 06 - 32_Neurophysiology

# 01 - 1. Physiology of Neuronal Activity

# 1. Physiology of Neuronal Activity

# 02 - A. Action Potentials

# A. Action Potentials

# 03 - B. Synaptic activity

# B. Synaptic activity

© SPMM Course 
1. Physiology of Neuronal Activity 
A. Action Potentials 
An action potential is initiated at the axonal hillock when the synaptic signals received by the dendrites 
and soma are sufficient to raise the intracellular resting membrane potential from -70 mV to the threshold 
potential of - 55mV. At -55mV, the Na+ channels present at the axon’s initial segment will open. The 
subsequent Na+ influx causes rapid reversal of the membrane potential from the negative values to +40 
mV. When the membrane potential reaches +40mV, the Na+ channels close and the voltage-gated K+ 
channels open. As K+ ions move out of the axon, the cell membrane gets “repolarized”. 
B. Synaptic activity 
A synapse is a junction between 2 nerve cells. Three types of synapses are noted in the nervous system. 
 Chemical synapses: Presynaptic neuron releases a chemical molecule on stimulation. This molecule 
acts on the next neuron to bring on a molecular effect or to propagate the impulse further downstream. 
o Depending on the effects noted on the postsynaptic neuron, a chemical synapse could be 
classified as either excitatory or inhibitory. Postsynaptic neurons are depolarized by activity at 
the excitatory synapses; inhibitory synaptic activity serves to hyperpolarize them. 
o In some instance the postsynaptic changes induced by an excitatory synapse may be sufficient to 
induce an action potential, but may serve to facilitate the likelihood of generating an action 
potential with further stimulation. This process is called facilitation. Due to this, additional 
input from several other presynaptic cells through other synapses may result in a spatial 
summation effect leading to an action potential. Similarly recurrent stimulation by the same 
synapse can result in temporal summation that leads to an action potential. 
 Electrical synapses: They bring on the response by electrical communication without chemical 
exchange. 
 Conjoint synapses: These have both electrical and chemical properties.

# 04 - 2. Neural basis of physiological functions

# 2. Neural basis of physiological functions

# 05 - A. Eating

# A. Eating

# 06 - B. Temperature

# B. Temperature

# 07 - C. Pain

# C. Pain

© SPMM Course 
2. Neural basis of physiological functions 
A. Eating 
The hypothalamus has 2 centers that control feeding behaviour. Ventromedial hypothalamus acts as the 
satiety centre while lateral hypothalamus acts as the feeding centre. 
Neurochemical substances such as ghrelin and neuropeptide Y act as mediators of increased appetite 
(orexigenic). Leptin, cholecystokinin and serotonin act as mediators of satiety (anorexigenic). 
Ghrelin is the only orexigenic substance produced outside of the CNS – it is synthesized in the gastric 
mucosa; adipose cells synthesize leptin. 
Food and food cues increase dopaminergic activity in nucleus accumbens (reward centre). Destruction of 
dopamine pathways reduces eating behaviour. In obesity, D2 receptors are reduced in the striatum. 
B. Temperature 
The hypothalamus has 2 centers that control body temperature. Preoptic anterior hypothalamus acts as a 
hypothermic centre while posterior hypothalamus acts as a hyperthermic centre. 
Stimulating preoptic anterior hypothalamus results in parasympathetic-mediated sweating and 
vasodilation, resulting in hypothermia. Stimulating posterior hypothalamus results in sympathetic drive, 
shivers and vasoconstriction, leading to hyperthermia. 
Body temperature varies diurnally; Lesions in the median eminence reduces the diurnal temperature 
variation. 
Certain drugs can induce malignant hyperthermia, but not through hypothalamic mechanism. An 
abnormal excitation-contraction coupling in skeletal muscles is responsible for this defect. 
Hyperthermia is also seen in Neuroleptic Malignant Syndrome (NMS) induced by neuroleptic use or 
levodopa withdrawal. 
C. Pain 
Thalamus plays a crucial role in pain perception while higher cortical centres are central to the 
localization and interpretation of pain signal. 
Thin unmyelinated C fibres or sparsely myelinated A-delta fibres carry pain sensation to dorsal horn of 
the spinal cord. Fast transmission takes place along lateral spinothalamic route to aid localization while 
slow transmission takes place through reticulothalamic tract to aid subjective sensation. 
Opioid receptors in dorsal horn and possibly those in brain stem (periaqueductal grey mater) modulate 
pain intensity. Descending fibres from serotonergic raphe nuclei also modulate pain perception; this may 
explain the role of tricyclic drugs in reducing chronic pain.

# 08 - D. Thirst

# D. Thirst

# 09 - E. Abnormalities in physiological drives

# E. Abnormalities in physiological drives

© SPMM Course 
Thalamic pain syndrome can occur in cases of stroke involving thalamoperforating branches of posterior 
cerebral artery. Patients have contralateral loss of sensation with burning or aching pain triggered by light 
cutaneous stimulation. 
D. Thirst 
Subfornical organ (SFO) and organum vasculosum of the lamina terminalis (OVLT) are 
circumventricular organs playing a crucial role in the perception of thirst. The hypothalamic 
paraventricular nucleus is also involved in the regulation of thirst. 
Angiotensin II acts as a neurotransmitter to propagate thirst signals to hypothalamus. Hypotension also 
stimulates thirst through pathways originating from the baroreceptors on aorta and carotid. 
Anti diuretic hormone (ADH) increases water reabsorption at renal tubules and thus helps maintain 
body’s fluid balance. The syndrome of inappropriate secretion of ADH (SIADH) may result from 
damage to paraventricular and supraoptic hypothalamic nuclei, or due to the use of drugs such as 
carbamazepine or chlorpromazine. Some tumours such as carcinoma of lung can also produce excess 
ADH. Low sodium and reduced osmolarity is noted in the presence of normal renal excretion of sodium 
and high urine osmolality. 
E. Abnormalities in physiological drives 
Disorder 
Clinical features 
Kluver-Bucy 
syndrome 
Bilateral lesions of amygdala and hippocampus results in placidity with decreased aggressive 
behaviour. Prominent oral exploratory behaviour and hypersexuality. Hypermetamorphosis 
(objects are repeatedly examined as if they were novel) is also seen. 
LaurenceMoon-Biedl 
Syndrome 
Obesity and hypogonadism along with low IQ, retinitis pigmentosa, and polydactyly. Diabetes 
insipidus is also seen. Autosomal recessive with genetic locus at 11q13 in most cases. No 
hypothalamic lesions have been found. 
Prader-Willi 
Syndrome 
Hypotonia, obesity with hyperphagia, hypogenitalism, mental retardation, short stature, 
impaired glucose tolerance. Abnormal control of body temperature and daytime 
hypersomnolence is related to hypothalamic disturbances. A reduction in oxytocin neurons and 
satiety neurons is noted. Associated with paternal deletion (genomic imprinting) at 15q11-q13 
Kleine-Levin 
Syndrome 
Compulsive eating behaviour with hyperphagia, hypersomnolence, hyperactivity, 
hypersexuality and exhibitionism. A hypothalamic abnormality sometimes preceded by a viral 
illness; often resolves by the third decade of life. 
Psychogenic 
polydipsia 
Excessive water consumption in the absence of hypovolemia or hypernatremia. May lead to 
water intoxication and serious electrolyte imbalance.

# 10 - 3. Neurodevelopment

# 3. Neurodevelopment

# 11 - A. Neurogenesis

# A. Neurogenesis

# 12 - B. Neuronal MigrationMyelination

# B. Neuronal Migration/Myelination

# 13 - C. Synaptic pruning

# C. Synaptic pruning

© SPMM Course 
3. Neurodevelopment 
A. Neurogenesis 
Early fetal life is a prolific period of neurogenesis. An active zone of nerve cell production is seen 
immediately around the ventricles of the neural tube. This is called a subventricular zone. Neurons 
produced here migrate outwards to the cortical plate. 
Thalamic axons that project to the cortical plate initially synapse on a transient layer of neurons called the 
subplate neurons. In normal development, the axons subsequently detach from the subplate neurons and 
proceed superficially to synapse on the true cortical cells. The subplate neurons then degenerate. In some 
patients with schizophrenia an abnormal persistence of subplate neurons has been noted, suggesting a 
failure of axonal path-finding. 
It is now known that continuous neurogenesis takes place in certain brain regions (particularly the dentate 
gyrus of the hippocampus and olfactory bulb) in adults. Stress reduces hippocampal neurogenesis; 
enriched environments, exercise and antidepressants promote hippocampal neurogenesis. There is some 
controversy around whether adult neurogenesis is observed in other brain regions. 
B. Neuronal Migration/Myelination 
Neuronal migration takes place in the first 6 months of gestation. 
Two types of migration are noted: radial and tangential. Radial migration is the primary mechanism by 
which excitatory neurons reach the cortex. Radial glial cells form scaffolding through their foot processes 
to guide the migrating neuronal cells. Successive populations of migrating neurons travel past the 
previously settled neurons (inside out pattern) to form radial stacks of cells (Rakic’s cortical columns). 
Most inhibitory interneurons in the external and internal granular layers are tangentially migrated 
neurons. 
Abnormalities in neuronal migration result in neurons failing to reach the cortex and residing in ectopic 
positions. This is called heterotopia. 
Myelination begins prenatally at around 4th gestational month; it is largely complete in early childhood 
(by 2 years), but does not reach its full extent especially in association cortices until late in the third decade 
of life. 
C. Synaptic pruning 
Synaptogenesis occurs very rapidly from the second trimester through the first ten years of life. The peak 
of synaptogenesis occurs within the first 2 postnatal years. By mid-childhood, more neurons and cellular 
processes are established than required for adult's brains. Thereafter a process of pruning or synaptic 
elimination takes place to select and preserve the most useful while eliminating the unnecessary neuronal 
connections in the adult's brain. This synaptic pruning continues through the early teen years. 
Neuronal numbers can be studied using a wide variety of markers including the density of D2 receptors. 
Before 5 years of age, D2 receptor density is greater than adult levels but regresses during the second

# 14 - D. Cerebral plasticity

# D. Cerebral plasticity

© SPMM Course 
decade. Dopamine receptors continue to decrease in adult years, but at a considerably slower rate of 2.2% 
reduction per decade. This rate is faster in males than in females. In schizophrenia, the rate of D2 receptor 
loss is faster (6.0% loss per decade) than in healthy men. 
While excessive or prolonged pruning is associated with schizophrenia, relative under-pruning is 
implicated in autism, wherein the size of certain brain regions may be larger than in healthy controls. 
D. Cerebral plasticity 
Cerebral plasticity refers to the capability of the brain to be molded. Cortical sensory maps change with 
variations in sensory input. Patients with phantom limb also show reorganization of sensory maps after 
amputation so that the representation of the amputated limb may occur on the cortical face area. Repeated 
practice also leads to a reorganization of brain’s functional regions. Such an effect is seen in musicians, 
jugglers and other professionals who repeatedly undertake a learned motor task.

# 15 - 4. Neuroendocrinology

# 4. Neuroendocrinology

# 16 - A. Pituitary gland

# A. Pituitary gland

© SPMM Course 
4. Neuroendocrinology 
A. Pituitary gland 
The pituitary gland has an anterior and posterior lobe. The anterior lobe secretes many hormones that are 
regulated by regulatory neurohormones produced by parvocellular neurons of the hypothalamus. The 
posterior lobe releases 2 hormones that are synthesized in the magnocellular cells of supraoptic nuclei and 
paraventricular nuclei of the hypothalamus. 
 Growth hormone excess causes acromegaly in adults or gigantism in children; low levels are 
associated with dwarfism. Exercise, sleep and stress increase GH release. The GH response to 
GHRH and the normal sleep-associated release of GH are altered in depression and anorexia 
nervosa. 
 Prolactin release is inhibited by dopamine from the hypothalamus; TRH, on the other hand, may 
facilitate the release of prolactin. Prolactin levels are increased during pregnancy, nursing and 
during sleep and exercise. Antipsychotics remove the inhibitory control of dopamine by blocking 
D2 receptors in the tuberoinfundibular tract. This leads to hyperprolactinaemia, gynecomastia in 
males and galactorrhea in females. Long standing prolactin increase may lead to osteoporosis. 
 Vasopressin (ADH) and oxytocin are peptides differing from each other in only two amino acids 
in their sequences. Vasopressin is thought to play a role in attention, memory, and learning. 
Release of vasopressin is increased by pain, stress, exercise, morphine, nicotine, and barbiturates 
and is decreased by alcohol. Oxytocin is implicated in mammalian bonding behavior, 
particularly in the initiation and maintenance of maternal behavior, social bonding, and sexual 
receptivity. 
 
Region 
Hormonal output 
Anterior pituitary 
o 
GH - growth hormone 
o 
LH - luteinizing hormone (a gonadotrophin) 
o 
FSH - follicle stimulating hormone (a gonadotrophin) 
o 
ACTH - adreno corticotrophic hormone (corticotrophin) 
o 
TSH - thyroid stimulating hormone (thyrotropin) 
o 
Prolactin 
Posterior pituitary 
o 
Vasopressin (ADH – antidiuretic hormone) 
o 
Oxytocin 
Hypothalamus 
o 
CRH - corticotrophin releasing hormone 
o 
GHRH - growth hormone releasing hormone 
o 
GnRH - gonadotrophin releasing hormone 
o 
TRH - thyrotrophin releasing hormone 
o 
SST – somatostatin (inhibits GH) 
o 
PIF - prolactin inhibitory factor (dopamine)

# 17 - B. Thyroid gland

# B. Thyroid gland

# 18 - C. Adrenal Cortex

# C. Adrenal Cortex

© SPMM Course 
B. Thyroid gland 
TRH from the hypothalamus stimulates the secretion of TSH from the pituitary. TSH in turn stimulates 
the thyroid gland to synthesize and release thyroxine T4 and triiodothyronine T3. T4 is the predominant 
form of thyroid hormone, but T3 is biologically more potent. T4 is converted into T3 by target organs as 
well as the brain. 
Exogenous administration of TRH produces a brisk response by increasing TSH concentration. In patients 
with depression, a blunted response to TRH administration is seen. Mania, alcohol withdrawal and 
anorexia can also cause blunted TRH response. 
The addition of T3 and T4 as supplements to antidepressant treatment has been shown to accelerate 
response in some patients, particularly women. Exogenous administration of thyroid hormones (e.g. in 
resistant depression) increases serotonergic transmission with decreased 5-HT1A sensitivity and increased 
5-HT2A sensitivity 
Nerve growth factor genes are activated by T3 during early development but not in the adult's brain. 
Lithium produces hypothyroidism especially in middle-aged women who are predisposed to carry 
antithyroid autoantibodies. 
Hypothyroidism is sometimes implicated in rapid cycling mood pattern in previously stable bipolar 
patients. Hyperthyroidism is associated with symptoms of generalized anxiety disorder. 
Hyperthyroidism 
Hypothyroidism 
Physical symptoms: Tachycardia, weight loss, heat 
intolerance, sweating 
Physical symptoms: Fatigue, weight gain, cold intolerance, 
dry skin 
Mental symptoms: Anxiety, irritability, poor 
concentration, agitation, emotional lability. 
Mental symptoms: Depression, reduced activity 
(psychomotor retardation), reduced libido and poor memory 
 
C. Adrenal Cortex 
CRH from the hypothalamus stimulates ACTH release from the anterior pituitary. ACTH in turn 
stimulates the release of cortisol from the adrenal cortex. Cortisol thus produced in turn inhibits both CRH 
and ACTH in a negative feedback loop to maintain homeostasis. This is called Hypothalamic-PituitaryAdrenal (HPA) axis. 
HPA axis is involved in regulation of stress response. With chronic stress the HPA feedback fails and 
continuous excess of cortisol is produced with deleterious consequences to the hippocampus where 
glucocorticoid receptors are abundant. Decreased hippocampal neurogenesis with atrophy of 
hippocampal dendrites results in shrinkage of the hippocampus. This disrupts long-term potentiation 
(LTP) and leads to impaired memory performance. A compensatory increase in dendritic arborization of

# 19 - Dexamethasone suppression test (DST)

# Dexamethasone suppression test (DST)

© SPMM Course 
neurons in the basolateral amygdala may occur, contributing to a memory bias towards negative events in 
chronic stress. 
Hypercortisolism (Addison's disease) 
Hypocortisolism (Cushing's syndrome) 
Physical symptoms: Apathy, fatigue, and 
depression 
Physical symptoms: Fatigue, weight gain, cold intolerance, 
dry skin 
Mental symptoms: Anxiety, irritability, poor 
concentration, agitation, emotional lability. 
Mental symptoms: Depression, mania, confusion, and 
psychotic symptoms. 
 
A diurnal variation in cortisol levels occurs in humans, with peak cortisol levels occurring around 6:007:00 AM. Hypercortisolemia with the loss of the normal diurnal variation have been reported in 
depression (especially in melancholic depression with the somatic syndrome), in some patients with 
mania (especially psychotic), obsessive-compulsive disorder and schizoaffective disorder. In PTSD 
hypocortisolemia is seen in a subgroup of patients; this may be due to aberrant feedback to the pituitary 
due to excessive glucocorticoid receptors – probably a genetic vulnerability. Low cortisol is also seen in 
chronic fatigue and fibromyalgia. 
Dexamethasone suppression test (DST) 
o Exogenous corticosteroids such as dexamethasone will suppress endogenous cortisol production if 
the HPA axis is intact. 
o In DST, 1mg dexamethasone is given at 11PM with baseline cortisol sampling; on the next day at 
8AM, 4PM and 11PM cortisol levels are measured again. If any one sample has >5mcg/L of cortisol, 
this indicates DST non-suppression. This demonstrates the failure of feedback suppression of 
ACTH/CRH and continuous production of endogenous cortisol despite administration of 
exogenous steroid (dexamethasone). 
o DST non-suppression is seen in depression and other psychiatric hyper cortisol emic states (also in 
organic hyper cortisol emic states such as Cushing’s). 
o The sensitivity of the DST for detecting major depression is modest (about 40%- 50%) but is higher 
(about 60%-70%) in very severe depression with psychotic as well as melancholic features. 
o DST non-suppression is non-specific to depression and is also seen in mania and schizoaffective 
disorder. In addition, a number of major medical conditions, pregnancy, severe weight loss and 
use of alcohol and certain other drugs (hepatic enzyme inducers that reduce dexamethasone 
availability - barbiturates, anticonvulsants, and others) can also produce DST non-suppression. 
o Despite the presence of depression, DST may suppress cortisol if the patient has Addison’s or 
hypopituitarism or taking steroids, high-dose benzodiazepines or indomethacin. 
o DST non-suppression does not increase the likelihood of antidepressant response. A negative test 
is not an indication for withholding antidepressant treatment. 
o Some data suggest that patients with DST non-suppression are less likely to respond to a placebo 
than those who show a suppression response.

# 20 - D. Pineal gland

# D. Pineal gland

© SPMM Course 
o Continued failure to suppress cortisol despite the apparent recovery from depression suggests an 
increased risk for relapse, poor prognosis and possibly later suicidal behaviour. 
 
D. Pineal gland 
The pineal gland is also called epiphysis. It contains pinealocytes that secrete both serotonin (in the day) 
and melatonin (in the night). The gland also contains calcium deposits that become more prominent with 
age (corpora arenacea or brain sand). 
The pineal gland contains the highest concentration of serotonin in the body. Melatonin is synthesized 
from serotonin by the action of serotonin-N-acetylase and 5-hydroxyindole-O-methyltransferase. 
The major regulator of melatonin synthesis is the light-dark cycle, with synthesis increased during 
darkness. The pineal gland is regulated by a major -adrenergic mechanism, and -antagonists such as 
propranolol decrease melatonin synthesis. 
Melatonin regulates circadian rhythms. It has both 
synchronizing and phase-shifting properties in the 
regulation of biological rhythms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDOCRINE CHANGES & SLEEP 
 
Start of sleep – increased testosterone 
Slow wave sleep – increased GH & SST; reduced 
cortisol 
REM sleep – reduced melatonin 
Early morning sleep – increased prolactin. 
 
Circadian rhythm development in the first 1 
month involves the emergence of the 24-hour 
core body temperature cycle; by 2 months 
progression of nocturnal sleeping is noted and in 
3 months, melatonin and cortisol rhythms are 
established.

# 21 - 5. Physiology of sleep

# 5. Physiology of sleep

# 22 - A. Measurement

# A. Measurement

# 23 - B. Architecture

# B. Architecture

# 24 - NREM sleep

# NREM sleep:

© SPMM Course 
5. Physiology of sleep 
A. Measurement 
 Actigraphy: This is used to quantify circadian 
sleep-wake patterns and to detect movement 
disorders during sleep; it uses a motion sensor. 
 Polysomnography (PSG): This includes EEG, 
electromyogram (EMG), electrooculogram 
EOG. ECG, oximetry and respiratory monitor 
can also be added. PSG helps in the diagnosis 
and monitoring of sleep apnoea, narcolepsy, 
restless legs & REM behavioural disorder. Some 
of the terms used in PSG are 
o Sleep latency: time from ‘lights out’ to sleep onset. 
o REM latency: Time from sleep onset to first REM episode. Normally ~90 minutes in adults. 
o Non-REM latency: Time from sleep onset to first Non-REM episode. 
o Sleep efficiency: (Total sleep time/total time in bed) X 100. 
o Multiple sleep latency test: This is used to assess daytime somnolence and daytime REM 
onset in narcolepsy. 
B. Architecture 
The average length of sleep is approximately 7.5 hours per night. Sleep is made up of non-rapid eye 
movement (NREM) and rapid eye movement (REM) phases. 
NREM sleep: 
o 75% of adult sleep is NREM. Most 
physiological functions are markedly 
lower in NREM than in wakefulness 
(decreased muscle tone, respiration, 
temperature and heart rate). 
o NREM is classified as stages 1 to 4 with 
increasing amplitude and decreasing 
frequency of EEG activity. Stages 3 & 4 
together constitute slow wave sleep 
(SWS). SWS dominates initial part of the 
sleep. 
o Features of non-REM sleep includes 
 
Increased parasympathetic activity 
(decreased heart rate, systolic blood 
pressure, respiratory rate, cerebral blood flow) 
 
Abolition of tendon reflexes 
 
The upward ocular deviation with few or no movements. 
• 5% of sleep 
• Drowsy period. When awoken from this stage one 
denies being asleep. 
• Shows low voltage theta activity, sharp V waves. 
Stage 1 NREM sleep 
Stage 1 NREM sleep 
•45% of sleep 
•Shows the development of sleep spindles and K 
complexes. 
Stage 2 NREM sleep 
Stage 2 NREM sleep 
•12% of sleep 
•Shows <50% delta waves. 
Stage 3 NREM sleep 
Stage 3 NREM sleep 
•13% of sleep 
•Shows >50% delta waves. 
•Physiological functions are at the lowest 
Stage 4 NREM sleep 
Stage 4 NREM sleep 
DREAMS 
Dreaming occurs at all stages of sleep, but the 
content varies. In non-REM sleep the dreams 
are thought-like as though the person is solving 
a problem. In REM sleep the dreams may be 
illogical and bizarre.

# 25 - REM sleep

# REM sleep

# 26 - C. Brain activity

# C. Brain activity

© SPMM Course 
 
Reduced recall of dreams if awaken. (Sleep terror is an NREM disorder. When awake after 
sleep terror episodes, children appear confused and do not recall what terrified them). 
REM sleep 
o 25% of adult sleep is REM. Darting eye movements are noted in REM despite other muscles being 
paralysed. REM sleep is characterized by a high level of brain activity and physiological activity 
similar to those in wakefulness. 
o In REM sleep behavioural disorder, muscular paralysis does not occur resulting in violent 
movements coinciding with brain activity. 
o EEG shows low-voltage, mixed-frequency (theta and slow alpha) activity similar to an awake state. 
Sawtooth waves are also seen. 
o In a typical night, a person cycles through five episodes of non-REM/REM activity. The REM 
episodes increase in length as the night unfolds. 
o Features of REM sleep: 
 
Increased sympathetic activity (increased heart rate, systolic blood pressure, respiratory 
rate, cerebral blood flow) 
 
Autonomic functions are active with penile erection or increased vaginal blood flow 
 
Increased protein synthesis 
 
Maximal loss of muscle tone with occasional myoclonic jerks 
 
Vivid recall of dream if awaken. (Nightmares occur in REM sleep – hence they are well 
recollected). 
C. Brain activity 
Apart from various oscillatory patterns, some specific patterns of electrical activity are also noted during 
sleep. 
 Sleep spindles 
 
Waves with upper alpha or lower beta frequency, seen in many stages but especially in stage 2. 
The waveform resembles a spindle with an initial increase in amplitude that decreases slowly 
 
Duration usually <1second. 
 
They usually are symmetric and are most obvious in the parasagittal regions. 
 K complex: 
 
K complex waves are large-amplitude delta frequency waves, sometimes with a sharp apex. 
 
They can occur throughout the brain but more prominent in the bifrontal regions. 
 
These may be mediated by thalamocortical circuitry. 
 
Usually symmetric, they occur each time the patient is aroused partially from sleep. 
 
Semiarousal often follows brief noises; with longer sounds, repeated K complexes can occur. 
 
Runs of generalized rhythmic theta waves sometimes follow K-complexes; this pattern is termed 
an arousal burst. 
 V waves: 
 
V waves are sharp waves that occur during sleep. They are largest and most evident at the vertex 
bilaterally and are usually symmetrical. 
 
Multiple V waves tend to occur especially during stage 2 sleep.

# 27 - D. Regulation

# D. Regulation

# 28 - Hypothalamic controls

# Hypothalamic controls

# 29 - Ascending Reticular Activating System Neurotr

# Ascending Reticular Activating System - Neurotransmitters

© SPMM Course 
 
Often they occur after sleep disturbances (e.g., brief sounds) and, like K complexes, may occur 
during brief semiarousals. 
 
D. Regulation 
Hypothalamic controls 
 The master clock of the brain is the 
suprachiasmatic nucleus (SCN) located in the 
anterior hypothalamus - this orchestrates 
circadian rhythms and is synchronized by signals 
from the retina. 
 SCN is reset each day by signals of light from the 
retina. Specialized melanopsin-containing retinal 
ganglion cells project via retinohypothalamic 
tract to the SCN. This provides light input 
independent of vision. 
 In the absence of solar guidance, the 24-hour 
sleep-wake cycle will gradually increase to 
approximately 26 hours –this is called freerunning. 
 Pineal melatonin secreted during darkness can 
also reset the SCN. Thus, melatonin promotes 
sleep in those with delayed sleep onset or jet lag. 
 The ventrolateral preoptic nucleus (VLPO) is called the sleep switch nucleus. It has projections to the 
main components of the ascending arousal system. The VLPO induces sleep by putting the brakes on 
the arousal nuclei. People with damage to their VLPO have chronic insomnia. 
 The VLPO must be inhibited so that people can wake up. This is brought about by a negative feedback 
from the monoaminergic system. The switching to arousal is then stabilised by orexin (also called 
hypocretin) neurons in the hypothalamus. Orexin neurons are mainly active during wakefulness and 
reinforce the arousal system. Patients with narcolepsy have reduced number of orexin neurons, 
leading to repeated somnolence during the day. 
Ascending Reticular Activating System - Neurotransmitters 
Neurotransmitter 
Cell Bodies 
Function 
Cholinergic 
Midbrain-pons nuclei 
REM on neurons. Activation brings on REM sleep 
Noradrenergic 
Locus coeruleus 
REM off neurons. Activation reduces REM sleep. 
Dopaminergic 
Periaqueductal gray matter 
D2 possibly enhances REM sleep 
Serotoninergic 
Raphe nuclei 
5HT2 stimulation possibly maintains arousal 
Histaminergic 
Tuberomammillary nucleus 
H1 stimulation possibly maintains arousal 
 
SLEEP & AGEING 
 
Newborns sleep about 16 hours a day. They spend >50% 
of sleep time in REM sleep. Sleep onset REM is also seen 
in neonates. 
 
By 3-4 months of age, the pattern shifts so that the total 
percentage of REM sleep drops to less than 40, and entry 
into sleep occurs with an initial period of NREM sleep. 
By late teens adult pattern of sleep is established. 
 
This distribution remains relatively constant until old 
age. Absolute reduction occurs in both slow-wave sleep 
and REM sleep in older persons. An increase in 
frequency of awakenings after sleep onset also occurs 
with age.

# 30 - E. Drugs and Disorders

# E. Drugs and Disorders

© SPMM Course 
E. Drugs and Disorders 
Disorder / drugs 
Changes 
Alcohol 
 
Increase SWS (chronic use – loss of SWS) 
 
Reduce initial REM but increase second half REM 
Alcohol 
withdrawal 
 
Loss of SWS 
 
Increased REM 
 
Intense REM rebound 
Anxiety 
disorders 
 
Increased stage 1 sleep (light sleep) 
 
Reduced REM, normal REM latency 
 
Reduced slow wave sleep 
Benzodiazepines 
 
Decrease sleep latency 
 
Increase sleep time 
 
Reduce stage 1 sleep 
 
Increase stage 2 sleep 
 
Reduce REM and SWS 
 
REM rebound on cessation 
 
Prevent the transition from lighter stage 2 sleep into deep, restorative (stages 3 and 4) sleep. 
Cannabis 
 
Increase SWS 
 
Suppress REM 
Carbamazepine 
 
Suppresses REM and increases REM latency 
 
Increases SWS 
Dementia 
 
Increased sleep latency & fragmentation 
 
Reduced sleep time 
Depression 
 
Loss of SWS slow wave sleep (first half) 
 
Increased REM (leading on to Early awakening) 
 
Reduced REM latency 
Lithium 
 
Suppresses REM and increases REM latency 
 
Increases SWS 
Opiates 
 
Decrease SWS & REM 
 
Withdrawal REM rebound 
Schizophrenia 
 
Inconsistent reduction in REM latency and slow wave sleep. 
 
N.B.: Antipsychotics have variable effects 
SSRIs 
 
Alerting due to 5HT2 stimulation 
 
May reduce REM latency 
 
Variable effects of REM suppression 
Stimulants 
 
Reduce sleep time by decreasing both REM sleep and SWS 
 
REM rebound on cessation (except modafinil) 
Tricyclics 
 
REM suppression (especially Clomipramine) 
 
Increased SWS and stage 1 sleep 
Z hypnotics 
 
Less effect on sleep architecture; Zopiclone may increase SWS

# 31 - 6. Neurophysiological measurements

# 6. Neurophysiological measurements

# 32 - A. EEG

# A. EEG

# 33 - Wave forms noted in EEG

# Wave forms noted in EEG

© SPMM Course 
6. Neurophysiological measurements 
A. EEG 
 EEG records the electrical activity of the brain. In psychiatric practice, it is primarily used to rule 
out seizures, monitor ECT and in polysomnogram for sleep disorders. 
 Standard EEG uses 21 electrodes placed on the scalp. Placement of the electrodes is based on the 
10/20 International System of Electrode Placement. This system measures the distance between 
readily identifiable landmarks on the head and then locates electrode positions at 10 percent or 
20 percent of that distance in an anterior-posterior or transverse direction. 
 Activation procedures could be used to bring up abnormal discharges. 
 Strenuous hyperventilation (most common, safe) 
 Photic stimulation using an intense strobe light 
 24 hours of sleep deprivation can lead to the activation of paroxysmal EEG discharges in 
some cases 
 EEG recording during sleep (natural or sedative induced) can also be used when the wake 
tracing is normal. 
Wave forms noted in EEG 
 
Waves 
Frequency 
Notes 
Beta 
>13Hz 
Some seen at frontal, central position in the normal waking EEG 
Alpha 
8 to 13 Hz 
Dominant brain wave frequency when eyes are closed and relaxing; occipitoparietal 
predilection. Disappears with anxiety, arousal, eye opening or focused attention. 
Dominance reduces with age. 
Theta 
4 to 8 Hz 
A Small amount of sporadic theta seen in waking EEG at frontotemporal area; 
prominent in drowsy or sleep EEG. Excessive theta in awake EEG is a sign of 
pathology. 
Delta 
<4 Hz 
Not seen in waking EEG. Common in deeper stages of sleep; the presence of 
focal/generalized delta in awake EEG is a sign of pathology. 
Mu 
7-11 Hz 
Occurs over the motor cortex. It is related to motor activity, characterized by arch like 
waves; gets attenuated by movement of the contralateral limb 
Lambda 
Single 
waves 
A single occipital triangular, symmetrical sharp wave produced by visual scanning 
when awake (e.g. reading) or in light sleep 
 
 Beta and alpha are called fast waves; theta and delta are slow waves. 
Newborns 
Newborns 
•Dominant 
delta and theta 
waves 
Infants 
Infants 
•Irregular 
medium- to 
high-voltage 
delta activity 
Early 
childhood 
Early 
childhood 
•Alpha range 
develops in 
posterior areas 
Midadolescence 
Midadolescence 
•EEG 
essentially has 
the appearance 
of an adult 
tracing by 1214 years. 
Adults 
Adults 
•Normal 
dominant 
alpha rhythm

# 34 - Abnormalities in EEG

# Abnormalities in EEG

© SPMM Course 
Abnormalities in EEG 
EEG in various disorders 
Absence seizures (petit-mal) 
Regular 3 Hz Complexes 
Alzheimer’s dementia 
Rarely normal in advanced dementia; may be helpful in differentiating 
pseudodementia from dementia 
Angelman’s syndrome 
1. EEG changes are notable by the age of 2. 
2. Prolonged runs of high amplitude 2–3 Hz frontal activity with 
superimposed interictal epileptiform discharges – all ages 
3. 3. Occipital high amplitude rhythmic 4–6 Hz activity facilitated by 
eye closure, is seen under the age of 12 years. 
4. 4. There is no difference in EEG findings in AS patients with or 
without seizures 
Antisocial personality disorder 
Increased incidence of EEG abnormalities in those with aggressive behaviour 
 ADHD 
Up to 60% have EEG abnormalities (spike/spike-waves) 
Borderline personality disorder 
Positive spikes: 14- and 6 per second seen in 25% of patients 
CJD 
Generalised periodic 1-2 Hz sharp waves are seen in nearly 90% patients with 
sporadic CJD. Less often in familial / hormonal transplant-related forms. NOT 
seen in a variant form. 
Closed head injuries 
Focal slowing (sharply focal head trauma) 
Focal delta slowing (subdural hematomas) 
Diffuse atherosclerosis 
Slowed alpha frequency and increased generalized theta slowing 
Herpes simplex encephalitis 
Episodic discharges are recurring every 1-3 seconds with variable focal waves 
over the temporal areas. 
Huntington’s dementia 
Initial loss of alpha; later flattened trace 
Infantile spasms (seen in 
tuberous sclerosis) 
Hypsarrhythmia [diffuse giant waves (high voltage, >400 microvolts) with a 
chaotic background of irregular, asynchronous multifocal spikes and sharp 
waves]. Clinical seizures are associated with a marked suppression of the 
background - called the electrodecremental response 
Infectious disorders 
Diffuse, often synchronous, high voltage slowing (acute phase of encephalitis) 
Metabolic and endocrine 
disorders 
Diffuse generalized slowing. Triphasic waves: 1.5 to 3.0 per second highvoltage slow-waves especially in hepatic encephalopathy. 
Neurosyphilis 
The non-specific increase in slow waves occurring diffusely over the scalp. 
Panic disorder 
Paroxysmal EEG changes consistent with partial seizure activity in one-third; 
focal slowing in about 25% of patients 
Seizures 
Generalized, hemispheric, or focal spike/ spike-wave discharge. 
Stroke 
Focal or regional delta activity 
Structural lesions 
Focal slowing / focal spike activity

# 35 - Effect of drugs on EEG

# Effect of drugs on EEG

# 36 - B. MEG

# B. MEG

# 37 - C. ERP

# C. ERP

© SPMM Course 
 Diffuse slowing of background is the most common EEG abnormality; it is nonspecific and 
signifies the presence of encephalopathy. Focal slowing suggests local mass lesions; e.g. edema, 
haematoma or focal seizure. 
 Epileptiform discharges when seen interictally, can be considered as hallmark of seizure 
disorder. But this is not a common finding. If this is lateralized and periodic, it may suggest an 
acute destructive brain lesion. 
 
Effect of drugs on EEG 
 
 
 
 
 
 
 
 
 
 
 
 
B. MEG 
 Magnetoencephalography (MEG) is used to measure the magnetic fields produced by electrical 
activity in the brain 
 In contrast to electric fields, magnetic fields are less distorted/impeded by the skull and scalp. 
 The scalp EEG is sensitive to both tangential and radial components of a current source in a spherical 
volume conductor, MEG detects only its tangential components. Thus, MEG may selectively measure 
the activity in the sulci, whereas scalp EEG measures activity both in the sulci and at the top of the 
cortical gyri. 
C. ERP 
 An ERP is a change in electrical brain activity stereotyped and time-locked to an event (e.g., stimulus), 
although it can also occur for the omission of an expected stimulus. ERPs allow the investigation of 
specific types of information processing by the brain. 
 ERPs are small relative to the spontaneous brain activity (background EEG) that is they have a low 
signal-to-noise ratio. To increase the signal-to-noise ratio, an often-used method is ERP averaging 
Psychotropics 
Antipsychotics 
Slowing of beta activity with increase in alpha, theta and delta activity 
Antidepressants 
Slowing of beta activity with increase in alpha, theta and delta activity 
Lithium 
Slowing of alpha or paroxysmal activity 
Anticonvulsants 
No effect on awake EEG 
Primarily sedating drugs – decrease alpha 
Barbiturates 
Effects are opposite to that of alcohol. Increased beta activity upon intoxication; 
generalized paroxysmal activity and spike discharges (even without overt fits) 
in withdrawal states. 
Benzodiazepines 
Increased beta; decreased alpha. Overdose leads to diffuse slowing 
Opioids 
Decreased alpha activity; increased voltage of theta and delta waves; in 
overdose, slow waves are seen. 
Primarily recreational drugs – increase alpha 
Alcohol 
Increased alpha activity; increased theta activity. Withdrawal increases beta. 
Delirium tremens has beta (fast) wave activity – other deliria have increased slow 
waves. 
Marijuana 
Increased alpha activity in frontal area of brain; overall slow alpha activity 
Cocaine 
Same as marijuana; longer lasting. 
Nicotine 
Increased alpha activity; in withdrawal, marked decrease in alpha activity 
Caffeine 
In withdrawal, increase in amplitude or voltage of theta activity

© SPMM Course 
 ERPs have polarity (positive [P] or negative [N]) and latency (the moment of peak occurrence after 
stimulus presentation, which is often indicated by the number attached to the labels of ERP activity). 
 The temporal resolution of EEG, MEG and ERP analysis is much higher than that of other 
neuroimaging methods like functional MRI, SPECT and PET, but these techniques lack the high spatial 
resolution of the MR techniques. 
 According to the time of occurrence ERPs, can be classified as early, mid latency and late. 
 The P300, a positive late ERP component around 
300 ms after stimulus presentation, is typically 
generated when a rare target stimulus is 
imbedded with more frequent stimuli e.g. 
(auditory ‘oddball’ protocol). The P300 is related 
to the maintenance of working memory. Decrease 
in P300 amplitude is well established as a 
biological trait marker in schizophrenia. 
 The Mismatch Negativity or MMN is a negative 
ERP component that is recorded between 100-200 
ms in response to low-probability deviant sounds 
(oddball) in a sequence of standard sound 
stimuli, when the participant is not actively 
attending to the deviants. The MMN is best seen 
in the difference wave between the ERP in 
response to the standard and deviant sounds. The 
MMN reflects involuntary information 
processing in auditory context, i.e. the mnemonic 
comparison of a given stimulus with a previous one that has already built up a trace in memory. The 
violation of the previously formed memory trace produces the MMN. Decreased MMN amplitude is 
noted in schizophrenia. 
 The Contingent Negative Variation (CNV) is a slow negative shift in the interval between two paired 
stimuli presented one after the other (S1 being the cue, S2 being the imperative stimulus prompting to 
respond). CNV reduction in central (midline) electrodes is noted in schizophrenia patients especially 
with long duration of illness with positive symptoms. 
 
 
 
 
 
 
•Basic sensory pathways can be studied by 
recording early ERPs. 
•These are also called ‘evoked potentials’ (EPs) or 
brain stem evoked responses (BAER) 
•They occur in response to sounds (Auditory EP, 
AEP), flashes (Visual EP, VEP) or electrical 
stimulation (Somatosensory EP, SEP). 
Early ERPs 
Early ERPs 
• These occur after BAER. 
•The three well known midlatency ERPs are N100, 
P50 and P200. 
•Their amplitudes reduce with repetition 
(habituation response / sensory gating). 
Midlatency ERPs 
Midlatency ERPs 
•Cognitive pathways can be studied by recording of 
ERPs related to the execution of psychological 
events such as attention, emotion or memory tasks. 
•P300 and MMN are late ERPs 
Late ERPs 
Late ERPs

© SPMM Course 
Notes prepared using excerpts from: 
 
 Seeman P. Pruning during development. Am J Psychiatry 1999’ 156:168. 
 Martin et al. Repetitive transcranial magnetic stimulation for the treatment of depression: 
systematic review and meta-analysis. British Journal of Psychiatry, 2003: 182, 480 -491. 
 The APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an 
overview of its current status in psychiatry. Am J Psychiatry 1987; 144:1253-1262 
 http://www.emedicine.com/neuro/TOPIC275.HTM 
 http://emedicine.medscape.com/article/1139332-overview 
 Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 10th Edition 
 George, MS et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biological 
Psychiatry, 2000: 47, 287 -295 
 Kaplan & Sadock Comprehensive Textbook of Psychiatry 9th ed – Pages 199-200. 
 Boyd et al. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr
1988: 147; 508–513 
 Ohayon MM et al. Meta-analysis of quantitative sleep parameters from childhood to old age in 
healthy individuals: Developing normative sleep values across the human lifespan. Sleep. 2004; 
27[7]: 1255-1273. 
 Walter et al. Contingent Negative Variation: An Electric Sign of Sensori-Motor Association and 
Expectancy in the Human Brain. Nature 1964: 203, 380 - 384 
 
DISCLAIMER: This material is developed from various revision notes assembled while preparing for 
MRCPsych exams. The content is periodically updated with excerpts from various published 
sources including peer-reviewed journals, websites, patient information leaflets and books. These 
sources are cited and acknowledged wherever possible; due to the structure of this material, 
acknowledgements have not been possible for every passage/fact that is common knowledge 
in psychiatry. We do not check the accuracy of drug related information using external sources; 
no part of these notes should be used as prescribing information.